Inside Therapeutics
About Inside Therapeutics
Inside Therapeutics revolutionizes nanoparticle manufacturing with intuitive platforms designed to accelerate and scale-up LNP-RNA vaccine development. The company offers innovative microfluidic-based systems, such as the TAMARA Nanoparticle Formulation System, which optimizes RNA therapy production by reducing time and costs associated with formula adaptations. Inside Therapeutics specializes in therapeutic applications, particularly in oncology, and provides solutions for the synthesis of various nanoparticle types including liposomes, LNP-xRNA, SLN, and PLGA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Seed (Jun 2024)
- Website: insidetx.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/inside-therapeutics-8518674 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.